Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/28/2012CN102395354A Microneedle array using porous substrate and process for producing same
03/28/2012CN102391377A Fusion protein capable of inducing and activating cancer targeting T-cells as well as preparation method and application of the fusion protein
03/28/2012CN102391370A Antimicrobial peptides, preparation method and application thereof
03/28/2012CN102391365A A group of new antibiotic peptides, preparation method thereof and use thereof
03/28/2012CN102391364A New antibacterial peptides as well as preparation method and application of the same
03/28/2012CN102391362A Group of animal-derived cationic antibacterial peptides and its application
03/28/2012CN102391361A Chickpea peptide with antioxidation effect and separation and purification method and application
03/28/2012CN102391360A Small peptide capable of resisting thrombosis and platelet aggregation
03/28/2012CN102391359A Histone deacetylase inhibitors (HDACIs), synthetic method thereof and pharmaceutical purposes thereof
03/28/2012CN102389574A Application of ITPKA (inositol-trisphosphate 3-kinase A) gene and expression protein thereof in preparing and screening anti-cancer medicament
03/28/2012CN102389573A Medicament for treating malignant glioma and preparation method thereof
03/28/2012CN102389571A Medicine sustained-release suppository used for in-vivo injection
03/28/2012CN102389569A Application of ErbB receptor agonist in preparing medicines for treating ischemic cerebrovascular diseases
03/28/2012CN102389567A New application of intermedin 1-53 in preparation of treatment medicament for lipid metabolism disorder
03/28/2012CN102389566A Huidouba peptide polysaccharide-containing composition used for treating type II diabetes
03/28/2012CN102389565A Medicament for treating or preventing animal disease
03/28/2012CN102389564A Compositions for use in treating myelodysplastic syndrome
03/28/2012CN102389413A Composition used for treating diabetes mellitus, and application thereof
03/28/2012CN102389402A Recombinant bovine basic fibroblast growth factor freeze-dried formulation for external application
03/28/2012CN102389392A Recombinant bovine basic fibroblast growth factor gel for eye use
03/28/2012CN102389030A Purpose of bacillus subtilis glycopeptide 168
03/28/2012CN102049035B Starch polysaccharide-iron compound preparation
03/28/2012CN101972449B Chinese medicinal material earthworm enzyme and peptide compound preparation and preparation method thereof
03/28/2012CN101843595B Formula of oral mucosa absorbing dosage form of medicines of polypeptides and proteins, and preparation method and application thereof
03/28/2012CN101747425B Protein relevant to retina photoreaction as well as coding gene and applications thereof
03/28/2012CN101724029B Anti-tumor protein and preparation method and application thereof
03/28/2012CN101624420B Group of novel cyclized antibiotic peptides containing gamma-core motif and preparation method as well as application thereof
03/28/2012CN101612389B Antiviral drug combination for livestock
03/28/2012CN101318994B Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof
03/28/2012CN101292951B Recombined human vascellum esoderma inhibin durative action preparation, preparation method and application thereof
03/28/2012CN101270379B Preparation method for abstracting collagen helical peptide from wood frog tissue
03/28/2012CN101270152B Peptide medicament series for accelerating medulla hematopoiesis cell proliferation
03/28/2012CN101264320B Oxygen-carrying blood substitute preparations
03/28/2012CN101188949B Egg-derived bone-strengthening composition
03/28/2012CN101184499B Intranasal administration of active agents to the central nervous system
03/27/2012US8143376 High affinity NY-ESO T cell receptor
03/27/2012US8143374 Polypeptide derivatives of parathyroid hormone (PTH)
03/27/2012US8143372 Synthetic regulators of ferritin protein nanocage pores and methods of use thereof
03/27/2012US8143265 Administering 2-aminopurine or a pharmaceutically salt thereof; optionally also administering an additional hypolipidemic agent; 2-AP and nonphosphorylatable eIF-2 alpha mutant inhibit eIF-2 alpha phosphorylation, inhibit foam cell formation and atherosclerosis development
03/27/2012US8143241 DNA damage repair inhibitors for treatment of cancer
03/27/2012US8143233 RNA aptamers and methods for identifying the same
03/27/2012US8143225 Incotinence; dosage form
03/27/2012US8143224 Oxidant resistant apolipoprotein A-1 and mimetic peptides
03/27/2012US8143222 Modular platform for targeted therapeutic delivery
03/27/2012US8143221 Use of ADNF polypeptides for treating peripheral neurotoxicity
03/27/2012US8143220 Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders
03/27/2012US8143219 Methods for prevention and treatment of acute renal injury
03/27/2012US8143218 Treatment of skin, and wound repair, with thymosin beta 4
03/27/2012US8143217 Use of DPP-IV inhibitor to reduce hypoglycemic events
03/27/2012US8143216 For increasing plasma concentration of insulin-like growth factor-1; oximination with polyoxyethylene glycol
03/27/2012US8143214 Protein-polymer conjugates
03/27/2012US8143212 Dalbavancin compositions for treatment of bacterial infections
03/27/2012US8143211 Bioactive peptides
03/27/2012US8143210 Enzyme treatment of foodstuffs for celiac sprue
03/27/2012US8143028 Bacillus licheniformis B1, alkalophilic enzyme solution and method of producing the same
03/27/2012US8143027 Method of making a plasminogen activator polypeptide with clot-specific streptokinase activity
03/27/2012US8143011 MAGE-C2 antigenic peptides and uses thereof
03/27/2012US8142810 Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
03/27/2012US8142805 Implantable devices including fixed tissues
03/27/2012US8142799 High potency clinical anti-craving treatment and method of use
03/27/2012US8142794 Hepatitis C virus vaccine
03/27/2012US8142791 Multi-modal cancer therapy using viral hitch-hiking
03/27/2012US8142786 Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein
03/27/2012US8142781 Fusion proteins for blood-brain barrier delivery
03/27/2012US8142778 Methods of treatment using CTLA-4 antibodies
03/27/2012US8142777 Monoclonal antibody specific to colon stimulating factor for use in treatment and prevention of rheumatoid arthritis
03/27/2012US8142776 For subcutaneous administration; hypertonic; useful for preventing self-association of reconstituted lyophilized formulations
03/27/2012US8142775 Crystallized oxalate decarboxylase and methods of use
03/27/2012US8142770 Drug comprising as the active ingredient proliferative vector containing survivin promoter
03/27/2012US8142764 Synthetic biofilm-inhibiting peptides
03/27/2012US8142762 Methods of using GPR101 receptors to identify modulators of hypothalamic proopiomelanocortin (POMC)-derived biologically active peptide secretion
03/27/2012CA2667068C 2-pyridinecarboxamide derivative having gk-activating effect
03/27/2012CA2603671C Insp163 polypeptides for the treatment or prevention of cancer and arthritis
03/27/2012CA2584482C Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
03/27/2012CA2540917C Polyarginine-modified liposome having nuclear entry ability
03/27/2012CA2529007C Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
03/27/2012CA2521784C Reversible pegylated drugs
03/27/2012CA2494796C Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant
03/27/2012CA2470245C Ifnar2 mutants, their production and use
03/27/2012CA2431487C Oligo or polyalkylene glycol-coupled thrombin inhibitors
03/27/2012CA2421087C Antisense insulin-like growth factor binding protein (igfbp)-2 oligodeoxynucleotides for prostate and other endocrine tumor therapy
03/27/2012CA2407423C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
03/27/2012CA2406179C Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors
03/27/2012CA2371922C Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
03/27/2012CA2362964C Fucosyl transferase gene
03/27/2012CA2329250C Peptide antiangiogenic drugs
03/27/2012CA2309903C Nucleic acid sequences encoding capsaicin receptor
03/27/2012CA2245496C Receptor protein designated 2f1
03/22/2012WO2012037551A2 Primary cell-derived biologic and wt1 synthetic long peptide vaccine
03/22/2012WO2012037534A1 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
03/22/2012WO2012037530A1 Stabilization of immunoglobulins and other proteins through aqueous formulations with sodium chloride at weak acidic to neutral ph
03/22/2012WO2012037519A2 Acceleration of wound healing by growth hormone releasing hormone and its agonists
03/22/2012WO2012037498A2 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
03/22/2012WO2012037485A2 Methods of inhibiting alphavirus replication and treating alphavirus infection
03/22/2012WO2012037397A2 Step-derived peptide for brain injury treatment
03/22/2012WO2012037380A2 Formulations of guanylate cyclase c agonists and methods of use
03/22/2012WO2012037370A1 Treatment of chronic nephropathies using soluble complement receptor type i (scr1)
03/22/2012WO2012037283A2 Admimistration of sns neuroprotective agents to promote hematopoietic regeration
03/22/2012WO2012037259A1 Novel inhibitors of hepatitis c virus replication
03/22/2012WO2012037212A1 Prolyl hydroxylase inhibitors as radiation mitigators and radiation protectors
1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 3163